acquired
Stage
About
DeepHealth develops AI-powered health informatics and diagnostic software for medical imaging; its products include enterprise imaging, diagnostic suites and population screening solutions (e.g., SmartMammo) to support radiology workflows and cancer detection. The company is a wholly-owned subsidiary of RadNet and recently acquired Kheiron, a UK-based breast cancer AI firm.
Explore DeepHealth's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.